Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays.
Chikungunya virus (CHIKV), an alphavirus, has recently caused epidemic outbreaks and is therefore considered a re-emerging pathogen for which no effective treatment is available. In this study, a CHIKV replicon containing the virus replicase proteins together with puromycin acetyltransferase, EGFP a...
Enregistré dans:
Auteurs principaux: | Leena Pohjala, Age Utt, Margus Varjak, Aleksei Lulla, Andres Merits, Tero Ahola, Päivi Tammela |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/24a78474c21d42d3bade824f3d0b1d7a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
SNAP-tagged Chikungunya Virus Replicons Improve Visualisation of Non-Structural Protein 3 by Fluorescence Microscopy
par: Roland Remenyi, et autres
Publié: (2017) -
Facile method for delivering chikungunya viral replicons into mosquitoes and mammalian cells
par: Hui-Chung Lin, et autres
Publié: (2021) -
Encephalitic Alphaviruses Exploit Caveola-Mediated Transcytosis at the Blood-Brain Barrier for Central Nervous System Entry
par: Hamid Salimi, et autres
Publié: (2020) -
A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs
par: Alexander Karlas, et autres
Publié: (2016) -
Chikungunya virus entry is strongly inhibited by phospholipase A2 isolated from the venom of Crotalus durissus terrificus
par: Igor Andrade Santos, et autres
Publié: (2021)